Sofinnova Partners
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Sofinnova Partners has raised €8.0M across 1 funding round from 1 investor, most recently a round in Apr 2013. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€8.0M
€8,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2013-04
latest 2013-04
Funding by year
EUR raised per yearSofinnova Partners — funding by year — interactive chart.
Data table
| Sofinnova Partners — funding by year | |
|---|---|
| 2013 | €8.0M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-04-01 | Other | €8.0M | Sofinnova Partners | View deal → |
Investors
1Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData